ROMPLIO 250

Romplio 250 Powder For Solution Injection 1’s belongs to the class of ‘platelet-stimulating agents’ primarily used to treat chronic immune thrombocytopenia in adults who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. Immune thrombocytopenia, often called idiopathic thrombocytopenic purpura (ITP), is an immune disorder characterised by low platelet counts.

Romplio 250 Powder For Solution Injection 1’s contains ‘Romiplostim,’ which is a thrombopoietin receptor agonist that functions similarly to thrombopoietin. Romplio 250 Powder For Solution Injection 1’s promotes platelet formation by activating the thrombopoietin receptor. Thereby, Romplio 250 Powder For Solution Injection 1’s helps treat immune thrombocytopenia effectively.

Romplio 250 Powder For Solution Injection 1’s will be administered by the healthcare professional. In some cases, Romplio 250 Powder For Solution Injection 1’s may cause common side effects like headache, joint pain, dizziness, trouble sleeping, muscle tenderness or weakness, pain in the arms and legs and indigestion. These side effects may vary individually. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Notify your doctor if you have allergic reactions to Romplio 250 Powder For Solution Injection 1’s or other medications. You must inform your doctor if you have leukaemia (blood or bone marrow cancer), bleeding or clotting disorders, or heart, kidney, or liver problems. Romplio 250 Powder For Solution Injection 1’s is not recommended during pregnancy unless indicated by the doctor. Romplio 250 Powder For Solution Injection 1’s may make you dizzy; hence drive or operate machinery only when you are alert. Romplio 250 Powder For Solution Injection 1’s is not recommended for use during breastfeeding.